However, the significant differences in the genotype and allele frequencies of the MspI polymorphism in the p53 gene between the schizophrenia and the lung cancer patient groups suggest that the p53 polymorphisms could be a marker for lower susceptibility to lung cancer genetically in schizophrenia patients. Here, TP53 is linked to lung cancer.